Evidence map›Paper›PMID 25482603›Full record

ArticlePrion2014

Pressure-assisted dissociation and degradation of "proteinase K-resistant" fibrils prepared by seeding with scrapie-infected hamster prion protein.

Kazuyuki Akasaka, Akihiro Maeno, Taichi Murayama, Hideki Tachibana, Yuzo Fujita, Hitoki Yamanaka, Noriyuki Nishida, Ryuichiro Atarashi

Abstract read
In one paragraph

Article in Prion, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kazuyuki Akasakaa Graduate School of Biology-Oriented Science and Technology ; Kinki University ; Kinokawa , Japan.
Akihiro Maeno
Taichi Murayama
Hideki Tachibana
Yuzo Fujita
Hitoki Yamanaka
Noriyuki Nishida
Ryuichiro Atarashi

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The crucial step for the fatal neurodegenerative prion diseases involves the conversion of a normal cellular protein, PrP(C), into a fibrous pathogenic form, PrP(Sc), which has an unusual stability against heat and resistance against proteinase K digestion. A successful challenge to reverse the reaction from PrP(Sc) into PrP(C) is considered valuable, as it would give a key to dissolving the complex molecular events into thermodynamic and kinetic analyses and may also provide a means to prevent the formation of PrP(Sc) from PrP(C) eventually in vivo. Here we show that, by applying pressures at kbar range, the "proteinase K-resistant" fibrils (rHaPrP(res)) prepared from hamster prion protein (rHaPrP [23-231]) by seeding with brain homogenate of scrapie-infected hamster, becomes easily digestible. The result is consistent with the notion that rHaPrP(res) fibrils are dissociated into rHaPrP monomers under pressure and that the formation of PrP(Sc) from PrP(C) is thermodynamically controlled. Moreover, the efficient degradation of prion fibrils under pressure provides a novel means of eliminating infectious PrP(Sc) from various systems of pathogenic concern.

Indexed as

CricetinaeAnimalsBrainEndopeptidase KPressureProtein ConformationProteolysisPrPC ProteinsPrPSc ProteinsScrapieEndopeptidase KPrPC ProteinsPrPSc ProteinsAFM atomic force microscopydissociation of prion fibrilsenzymatic degradation of prion fibrilsPK proteinase Kpressure-assisted dissociationproteinase K-resistant prion fibrilsPrPC cellular form of prion proteinPrPSc scrapie form of prion proteinQUIC quaking-induced conversionRecombinant Hamster prion proteinrHaPrP recombinant Hamster prion proteinrHaPrPres PK-resistant recombinant Hamster prion proteinWestern blotting

Identifiers

PMID25482603
PMCPMC4601478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.